Description
Dapawalk GM 10/1/500 is a high-efficacy oral hypoglycemic formulation combining:
| Ingredient | Strength | Function |
|---|---|---|
| Dapagliflozin 10 mg | SGLT2 Inhibitor | Helps eliminate excess glucose via urine |
| Glimepiride 1 mg | Sulfonylurea | Improves insulin action |
| Metformin (ER) 500 mg | Biguanide | Reduces liver glucose production |
This triple-action formula supports better long-term glucose control, reduces HbA1c, and promotes weight-friendly diabetes management. Suitable for adults with Type 2 Diabetes needing improved glycemic stability under medical supervision.
💊 Clinical Benefits
✔ Helps lower fasting and post-meal blood sugar
✔ Enhances insulin response naturally
✔ Supports weight management for diabetes patients
✔ Works effectively with lifestyle modifications
✔ ER formulation ensures smooth, controlled drug release
🧪 Packaging
📍 10 × 10 Tablets (Alu-Alu / Blister Pack)
⚠️ Safety & Precautions
-
Use only under physician supervision
-
Not recommended for Type 1 Diabetes or ketoacidosis
-
Avoid heavy alcohol consumption
-
Monitor kidney function in long-term use
Franchise + Third-Party Manufacturing
Biophar Lifesciences is a top ISO-certified pharma company offering Diabetes range pharma franchise and third-party manufacturing services across India. With WHO-GMP certified facilities and strong supply capability, Biophar delivers high-quality antidiabetic products like Dapawalk GM at competitive rates. Our diabetic range is widely demanded by healthcare practitioners and distributors due to its stable results, premium formulation, and reliable packaging. Entrepreneurs, wholesalers, and distributors seeking a PCD pharma franchise for diabetes medicines or Diabetic product manufacturing can partner with Biophar for assured quality, marketing support, and monopoly rights.
